CHINA PRETRIALS 2010 ADVISORY BOARD

Ernest Bush, Ph.D. Vice President & Scientific Director CHINA PRECLINICAL MANAGEMENT SERVICES	John Gong, Ph.D, M.D. Vice President & CTO JOINN LABORATORIES	Helen Han Hsu, Ph.D. Vice President, Head of Preclinical Development, Asia Pacific JOHNSON & JOHNSON

Edward Hu, Ph.D. Chief Operating Officer WUXI APPTEC	Steven Hutchins, Ph.D. Senior Vice President, Strategic Business Development US EVOTEC	Kewen Jin, Ph.D. General Manager CHARLES RIVER LABORATORIES

Steve Yang, Ph.D. Vice President, Head of R&D, Asia PFIZER CHINA R&D CENTER	Yi Yang, M.D., Ph.D. Head of Preclinical Safety, China R&D SANOFI-AVENTIS	Nick Zhang, Ph.D. Head of CPP/PHAD China CHINA NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH

Guoxin Zhu, Ph.D Director, Discovery Chemistry Research & Technology ELI LILLY & COMPANY

About Your Organizer

Jon E. Liong, Managing Partner, LYCHEE GROUP
Jon brings 10 years of success in the strategic planning, organization and marketing of over 100 pharmaceutical and biotech business-to-business conferences. He conceived and launched the "IMPACT CHINA: Pharmaceutical Global R&D" series, which was the first-ever global R&D event covering China's life sciences industry. The meeting helped foster early collaborations between Western companies and all aspects of China's nascent pharmaceutical industry.